About conolidine
Andy Chevigné and his group, RTI-5152-12 is postulated to increase the levels of opioid peptides that bind to classical opioid receptors from the brain, causing heightened painkilling action. The LIH-RTI study groups recognized a collaboration settlement and submitted a joint patent application in December 2020.The opioid procedure within the huma